FDA clears Medicrea’s PASS XS and LigaPASS XS for pediatric spinal deformity: 5 key notes

The FDA cleared Lyon, France-based Medicrea’s PASS XS posterior fixation and LigaPASS XS band connector components.

Advertisement

Here are five key notes:

 

1. These two cleared components are designed for pediatric spinal deformities in small-stature patients.

 

2. Medicrea collaborated with pediatric spine surgeons to create implants for pediatric deformity surgery.

 

3. Surgeons may use the extra-small PASS and LigaPASS components to treat pediatric patients with about 40 percent less implant volume in each surgery.

 

4. These extra-small components feature the lowest construct profile in-situ in the market.

 

5. Medicrea expects to report the first surgery with the PASS XS and LigaPASS XS components in the United States in November.

 

More articles on devices:
Transforming SCI treatment — The promise of InVivo’s Neuro-Spinal Scaffold
Minimally invasive spine surgery, data gathering, value-based care & more: Key thoughts from NuVasive’s Spine Summit
OrthoCarolina completes 100th Mazor Robotics surgical case: 3 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.